Nevro Announces U.S. Launch of Senza(R) Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain

Senza Omnia Offers Maximum Versatility by Delivering Nevro's Proprietary HF10 Therapy and All Other Available SCS FrequenciesREDWOOD CITY, Calif., Nov. 5, 2019 -- (Healthcare Sales & Marketing Network)-- Nevro Corp. (NYSE: NVRO), a global medical dev...Devices, FDA
Nevro Corp, Senza Omnia, Spinal Cord Stimulation, HF10 therapy